Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ebumab Sandbox ApS
APS
Active
Advertising protection
CVR 43575627
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Ebumab Sandbox ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JH
Johan Henrik Faber
Management
Management
2022
HH
Hans Heugh Wandall
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SE
Søren Erik Bjørn
Board of Directors
Board of Directors
2022
TD
Thomas Dal Stenfeldt Batchelor
Chairman
Chairman
2022
Shareholders
As of last annual report
100%
Shareholder
Type
Ownership
Votes
Since
Ebumab Holding ApS
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ebumab Sandbox ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
